IL160626A0 - Antiviral protease inhibitors - Google Patents

Antiviral protease inhibitors

Info

Publication number
IL160626A0
IL160626A0 IL16062602A IL16062602A IL160626A0 IL 160626 A0 IL160626 A0 IL 160626A0 IL 16062602 A IL16062602 A IL 16062602A IL 16062602 A IL16062602 A IL 16062602A IL 160626 A0 IL160626 A0 IL 160626A0
Authority
IL
Israel
Prior art keywords
protease inhibitors
antiviral protease
antiviral
inhibitors
protease
Prior art date
Application number
IL16062602A
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir Ab filed Critical Medivir Ab
Publication of IL160626A0 publication Critical patent/IL160626A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/36—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
IL16062602A 2001-08-29 2002-08-29 Antiviral protease inhibitors IL160626A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0102892A SE0102892D0 (en) 2001-08-29 2001-08-29 Antivirals I
PCT/SE2002/001549 WO2003018537A1 (en) 2001-08-29 2002-08-29 Antiviral protease inhibitors

Publications (1)

Publication Number Publication Date
IL160626A0 true IL160626A0 (en) 2004-07-25

Family

ID=20285183

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16062602A IL160626A0 (en) 2001-08-29 2002-08-29 Antiviral protease inhibitors

Country Status (6)

Country Link
EP (1) EP1421060A1 (en)
JP (1) JP2005501118A (en)
CA (1) CA2458040A1 (en)
IL (1) IL160626A0 (en)
SE (1) SE0102892D0 (en)
WO (1) WO2003018537A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160038439A1 (en) * 2013-04-18 2016-02-11 Xi'anlibang Pharmaceutical Technology Co., Ltd. Use of 7-a-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-estra-1,3,5(10)- triene-3,17B-diol and derivatives thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701245D0 (en) * 1997-04-04 1997-04-04 Bjoern Classon antivirals

Also Published As

Publication number Publication date
CA2458040A1 (en) 2003-03-06
EP1421060A1 (en) 2004-05-26
SE0102892D0 (en) 2001-08-29
JP2005501118A (en) 2005-01-13
WO2003018537A1 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
GB0125445D0 (en) Protease Inhibitors
HK1059932A1 (en) Metalloproteinase inhibitors
PL370909A1 (en) Cis-imidazolines as mdm2 inhibitors
IL157570A0 (en) Metalloproteinase inhibitors
AU4344101A (en) Protease inhibitors
EP1499336A4 (en) Protease inhibitors
IL157650A0 (en) Metalloproteinase inhibitors
IL153421A0 (en) Protease inhibitors
AU2003269984A8 (en) Protease inhibitors
IL151087A0 (en) Protease inhibitors
AU2002360673A8 (en) Gp41 inhibitor
EP1401453A4 (en) Protease inhibitors
GB0114627D0 (en) Partitioned can
HUP0303185A3 (en) Glyt-1 inhibitors
AU2003263738A8 (en) Protease inhibitors
IL155997A0 (en) Protease inhibitors
GB0123467D0 (en) Carbocyclic HIV Protease inhibitors
IL160626A0 (en) Antiviral protease inhibitors
AU2003287325A8 (en) N-cycloalkylglycines as hiv protease inhibitors
GB2380707B (en) Art cubes
AU2003304496A8 (en) Protease inhibitors
AU2003233642A8 (en) Protease inhibitors
AU2003265240A8 (en) Protease inhibitors
AU2003269878A8 (en) Protease inhibitors
GB0101135D0 (en) Inhibitors